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ABSTRACT
Background: Anemia in women of reproductive age (WRA) (age
range: 15–49 y) remains a public health problem globally, and re-
ducing anemia in women by 50% by 2025 is a goal of the World
Health Assembly.
Objective: We assessed the associations between anemia and mul-
tiple proximal risk factors (e.g., iron and vitamin A deficiencies,
inflammation, malaria, and body mass index) and distal risk factors
(e.g., education status, household sanitation and hygiene, and urban
or rural residence) in nonpregnant WRA.
Design: Cross-sectional, nationally representative data from 10 surveys
(n = 27,018) from the Biomarkers Reflecting Inflammation and
Nutritional Determinants of Anemia (BRINDA) project were an-
alyzed individually and pooled by the infection burden and risk in
the country. We examined the severity of anemia and measured the
bivariate associations between anemia and factors at the country
level and by infection burden, which we classified with the use of
the national prevalences of malaria, HIV, schistosomiasis, sanitation,
and water-quality indicators. Pooled multivariate logistic regres-
sion models were constructed for each infection-burden category
to identify independent determinants of anemia (hemoglobin con-
certation ,120 g/L).
Results: Anemia prevalence was w40% in countries with a high
infection burden and 12% and 7% in countries with moderate and
low infection burdens, respectively. Iron deficiency was consistently
associated with anemia in multivariate models, but the proportion of
anemic women who were iron deficient was considerably lower
in the high-infection group (35%) than in the moderate- and low-
infection groups (65% and 71%, respectively). In the multivariate
analysis, inflammation, vitamin A insufficiency, socioeconomic status,
and age were also significantly associated with anemia, but malaria
and vitamin B-12 and folate deficiencies were not.
Conclusions: The contribution of iron deficiency to anemia varies
according to a country’s infection burden. Anemia-reduction pro-
grams for WRA can be improved by considering the underlying
infection burden of the population and by assessing the overlap of
micronutrient deficiencies and anemia. Am J Clin Nutr 2017;106
(Suppl):416S–27S.
Keywords: anemia, determinants, inflammation, iron, malaria,
micronutrient deficiencies, risk factors, women, women of repro-
ductive age
INTRODUCTION
Anemia in women of reproductive age (WRA) (age range:
15–49 y) remains a public health problem globally, and reducing
anemia in WRA by 50% by 2025 is 1 of 6 global nutrition
targets that have been set forth by the World Health Assembly
(1). As of 2011, w496 million nonpregnant women were anemic
(2), which is an increase of w50 million nonpregnant women
from 1995 (3). According to a recent systematic review and
Report of the collaborative research group called Biomarkers Reflecting
Inflammation and Nutritional Determinants of Anemia (BRINDA), which
was formed in 2012 by the Centers for Disease Control and Prevention
(CDC), the Global Alliance for Improved Nutrition (GAIN), and the Eunice
Kennedy Shriver National Institute of Child Health and Human Development
(NICHD). For additional information on the BRINDA project, please see
www.BRINDA-nutrition.org.
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meta-analysis, anemia during pregnancy increased risks of
poor birth outcomes such as preterm birth, low birth weight, and
perinatal and neonatal mortality (4). Maternal mortality has also
been associated with hemoglobin concentrations during pregnancy
(5) with risk of maternal mortality decreasing by 25% for every
10-g/L increase in hemoglobin. Moreover, anemia results in re-
duced work productivity in nonpregnant WRA (6–9), which is likely
due to reduced oxygen-carrying capacity in an individual’s blood (10).
The Biomarkers Reflecting Inflammation and Nutritional
Determinants of Anemia (BRINDA) project developed its own
anemia causative framework that is presented in the methodologic
overview in this supplement, which is an open access publication
(11). Compared with other conceptual models (12, 13), the BRINDA
anemia framework details the associations between micronutrient
deficiencies, inflammation, hemoglobinopathies, and anemia. The
framework also illustrates that malaria can cause anemia through the
destruction of erythrocytes but does not cause iron loss (14), and expo-
sure to unsafewater and inadequate sanitation, a lack or nonuse of bed
nets, food insecurity, and household poverty (12) likely contribute to
anemia by increasing the risk of infectious diseases and decreasing the
availability and consumption of micronutrient-rich foods.
Iron deficiency, in particular, has long been considered a major
cause of anemia in most populations. It has long been presumed
that iron deficiency contributes to 50% of all anemia (15). This
approximation has been frequently referenced (15–17) beginning
with a simple calculation derived in 1985 under the presumption
that men do not become iron deficient because they do not ex-
perience rapid growth or menstruation, but they do encounter the
other risk factors for anemia (18). This approximation has been
supported by findings from Stoltzfus et al. (5) and, more recently,
by Stevens et al. (3) who showed that 50% of anemia in women
was amenable to iron supplementation by applying hemoglobin
shifts from meta-analyses of supplementation trials to new global
estimates of anemia prevalence. In addition, a recent analysis that
used data from a meta-analysis on the response of hemoglobin to
iron-fortification studies concluded that iron deficiency was the
primary contributor to anemia in multiple geographic settings (13).
Although these studies reached similar conclusions concerning the
etiology of anemia, they each modeled the determinants of anemia
and the proportion of anemia that were attributable to common risk
factors such as iron deficiency. Multiple individual studies that have
examined the determinants of anemia with the use of individual-level
data on micronutrient and disease status have shown that the pro-
portion of anemia that is attributable to iron deficiency is highly
variable and that other risk factors may play more important roles in
determining hemoglobin concentration and anemia (19, 20).
The objectives of this articlewere to assess the association between
anemia and posited risk factors in nonpregnant WRA in 10 surveys.
Although hemoglobin is routinely assessed in health and nutrition
surveys, it is less common to have survey data that include mea-
surements of several potential risk factors for anemia. The BRINDA
project is uniquely positioned to address this knowledge gap through
a secondary analysis of cross-sectional survey data that include
anemia and other factors such as inflammation and micronutrient
biomarkers and household-level risk factors for anemia (21).
METHODS
We conducted these analyses with the use of data from the
BRINDA project (www.BRINDA-nutrition.org); details of the
project objectives and methodology have previously been pub-
lished (21). The BRINDA protocol was reviewed by the institu-
tional review boards of the NIH and was deemed to be non–human
subjects research. The surveys included in the BRINDA project
were nationally or regionally representative, and the inclusion
criteria were as follows: 1) surveys were conducted between
2004 and 2012; 2) surveys included preschool children or non-
pregnant WRA; and 3) surveys measured $1 indicator of ane-
mia (hemoglobin), iron (ferritin or soluble transferrin receptor),
or vitamin A status [(retinol-binding protein (RBP) or retinol)]
and $1 biomarker of inflammation [(a-1-acid glycoprotein
(AGP) or C-reactive protein (CRP)] (21). In this analysis, we
included surveys with measures of hemoglobin in nonpregnant
WRA (age range: 15–49 y) and examined data from 10 nationally
representative cross-sectional surveys from 3 countries in the
Americas (Colombia, Mexico, and the United States), 3 coun-
tries in West Africa (Cameroon, Coˆte d’Ivoire, and Liberia), one
country in Central Asia (Georgia), and 2 countries in Southeast
Asia and the Pacific (Laos and Papua New Guinea). We excluded
Papua New Guinea from analyses that were related to iron
status because only soluble transferrin receptor and not ferritin
was measured. Descriptions of the original surveys and rele-
vant references are included in the methodologic summary in
this issue (11).
Laboratory analyses
Hemoglobin concentrations were measured with the use of a
Beckman Coulter MAXM hematology flow cytometer (Beckman
Coulter Inc.) in the United States or a portable hemoglobinometer
in Georgia (HumaMeter; Human GmbH) and in all other
countries (HemoCue; HemoCue AB). Venous or capillary blood
was collected from each respondent, and plasma or serum was
stored at 2208C until analysis; the Papua New Guinea survey
used dried blood spots. Ferritin, RBP, CRP, and AGP concen-
trations were assessed with the use of a sandwich ELISA at the
VitMin Laboratory in Willstaett, Germany, in 5 of 10 WRA data
sets (22). CRP was measured with the use of in-country methods
in Mexico (Behring Nephelometer 100 Analyzer; Behringwerke
AG) and the United States (immunoassay). Serum retinol was
measured via HPLC (23) in the United States. Malaria was assessed
with the use of microscopy in Coˆte d’Ivoire (24), a Paracheck Pf
rapid diagnostic test (Orchid Biomedical System) in Liberia, and
the plasma histidine-rich protein 2 (Cellabs Pty Ltd.) in Came-
roon. Additional information on laboratory methods is further
described in the methodologic overview in this supplement (11).
Grouping countries by infection burden
We categorized surveys into 3 groups representing risk and
burden of infectious disease and inflammation (hereinafter re-
ferred to as infection burden), and carried out the data analysis
separately for each group. The logic for this approach was that the
causes of anemia will vary depending on environmental and
socioeconomic characteristics and the intensity of exposure to
infections and to inflammation-inducing conditions (e.g., obesity).
Countries were assigned to infection groups by adapting the ap-
proach developed by Petry et al. (25), whereby national-level prev-
alence estimates of malaria, HIV infection, access to improved
drinking water and sanitation facilities, and schistosomiasis were
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used to calculate an equally weighted infection score for each
country and to group countries on the basis of their infection
scores (see Supplemental Table 1 for details). Our calculations
varied from those used by Petry et al. (25) in the following 2
ways: 1) our infection score did not include the prevalence of
obesity because we aimed to group countries on the basis of
characteristics that are related to infectious disease only, and 2)
the ranges used for each infection group were modified slightly
because of the relatively small number of data sets that were
available to the BRINDA project. With the use of this approach,
Cameroon, Coˆte d’Ivoire, Liberia, Laos, and Papua New Guinea
were classified as countries with a high infection burden; Mexico
and Colombia were classified as countries with a moderate in-
fection burden; and Georgia and the United States were classified
as having a low infection burden.
Determinants of anemia and case definitions
The WHO definitions of anemia status were used to classify
anemia in nonpregnant women (26). Any anemia was defined as a
hemoglobin concentration ,120 g/L. Severe, moderate, and
mild anemia were defined as hemoglobin concentrations ,80,
80–109, and 110–119 g/L, respectively. Hemoglobin concen-
trations were adjusted for altitude and the intensity of cigarette
smoking according to WHO procedures (26) in the Colombia,
Georgia, Papua New Guinea, and Mexico 2006, and Mexico
2012 surveys. In Laos, hemoglobin was adjusted only for alti-
tude, and in the United States, hemoglobin was adjusted only for
smoking. No adjustments to hemoglobin were made in the Coˆte
d’Ivoire, Cameroon, and Liberia surveys. Hemoglobin concen-
trations were considered biologically implausible when values
fell outside of 40–180 g/L and were set to missing. With the use
of the WHO classification of the public health significance of
anemia (15), an anemia prevalence of 5.0–19.9% was used to
denote a mild public health problem, a prevalence of 20.0–
39.9% was used to denote a moderate problem, and a prevalence
of $40% was used to denote a severe problem. A prevalence of
,5% was considered normal.
Ferritin was used as the indicator of iron status in population-
based surveys according toWHO recommendations (27). Ferritin
concentrations were adjusted for inflammation as measured via
AGP and CRP concentrations with the use of the internal re-
gression correction (IRC) approaches that are defined by Namaste
et al. (28) in this supplement. Briefly, ferritin was adjusted with
the use of both CRP and AGP when available and with only
CRP in countries that did not measure AGP. The IRC approach
enabled a continuous, rather than categorical, adjustment of ferritin
concentrations and resulted in a greater difference from the un-
adjusted prevalence derived from previous methods that adjusted
ferritin when inflammation levels reached certain thresholds (29,
30). An illustrative example of adjusting ferritin for CRP and AGP
with the use of the IRC approach is presented in Supplemental
Figure 1. RBP and retinol (in the United States only) were
used as measures of vitamin A status. Although RBP and ret-
inol concentrations are affected by inflammation, the findings
by Larson et al. (31) in this supplement show that the relations
between these indicators and inflammatory markers in women
in the BRINDA data set were weak and inconsistent. As such,
we did not adjust RBP or retinol concentrations for inflammation
for this analysis.
Iron deficiency was defined as an adjusted ferritin concen-
tration ,15 mg/L, which indicated depleted iron stores (27). Iron-
deficiency anemia was defined as concurrent iron deficiency (i.e., a
ferritin concentration ,15 mg/L) and anemia (i.e., hemoglobin
concentration ,120 g/L). Vitamin A deficiency and vitamin A
insufficiency were defined as RBP or retinol concentrations ,0.7
and ,1.05 mmol/L (32), respectively. Folate deficiency was de-
fined as a plasma or serum folate concentration ,10 nmol/L, and
vitamin B-12 deficiency was defined as a serum cobalamin
concentration ,150 pmol/L (33). Folate and vitamin B-12 were
measured in the Coˆte d’Ivoire, Mexico 2012, and US surveys,
folate alone was in measured in Georgia, and vitamin B-12 alone
was measured in Colombia. Folate and vitamin B-12 concentra-
tions were not corrected for inflammation.
CRP was measured in all surveys, but AGP was only measured
in the Cameroon, Coˆte d’Ivoire, Laos, Liberia, and Papua New
Guinea surveys. Because not all surveys measured both CRP and
AGP, we classified inflammation status into 2 categories as follows:
no inflammation and any inflammation. No inflammation was
defined as having both a normal CRP concentration (#5 mg/L)
and a normal AGP concentration (#1.0 g/L) or, in the absence
of an AGP value, having a normal CRP concentration. Survey
subjects with no biochemical measure of inflammation were
recoded as missing values. Accordingly, ferritin values were also
recoded as missing if no data on inflammation was available. BMI
(in kg/m2) was classified as follows: ,18.5 (underweight), 18.5–
24.9 (normal), 25.0–29.9 (overweight), and $30.0 (obese) (34).
Three household-level factors that were related to water,
sanitation, hygiene, and socioeconomic status (SES) were ex-
amined as potential covariates of women’s anemia status. Water,
sanitation, and hygiene indicators were defined according to
UNICEF-WHO guidelines (35) by classifying the household
drinking water source as being safe or unsafe and the household
sanitation facility as being improved or unimproved. Open de-
fecation was used as a third category of household sanitation and
was comprised of households with no sanitation facility or those
reporting that defecation is usually conducted in the bush or river.
Household SES was defined within each survey with the use of
appropriate available data. SES was based on household income in
Papua New Guinea, the poverty-index ratio in the United States
(36), and an asset score in all other surveys (37). Because of a lack
of data on household assets or income, SES could not be calcu-
lated for Georgian women. For bivariate analyses, the lowest SES
group, such as the lowest 2 quintiles of asset scores, was compared
with a reference group of all households with higher SES.
Statistical analysis
Analyses were conducted with SPSS version 23 software (IBM
Corp.) with the complex survey module unless otherwise noted.
Stratified sampling was done in all surveys from which data were
included in the combined BRINDA data set. As a result, each
individual survey data set included standardized sampling weights
to correct for an unequal probability of selection within that survey.
For pooled analyses, population-based weights were rescaled so
that the sum of the weights within each study was proportional to
the size of the population represented by the data set (i.e., number of
WRA).
Univariate statistics were calculated for each country and in-
fection group to describe the surveyed women’s mean age, mean
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hemoglobin concentration, and proportions of anemia, micro-
nutrient deficiencies, inflammation, and malaria. Bivariate analyses
of the associations between anemia prevalence and demographic
and nutrition factors was done for each survey data set and, after
categorizing the data sets by infection burden, for each infection
group. For each risk factor and respective subgroup, the preva-
lence of anemia was calculated, and the significance of the
difference between anemia prevalence for each factor’s subgroups
was judged with the use of Pearson’s chi-square test. P , 0.05
was used to determine significance in the bivariate analyses.
Factors with significant associations with anemia in the bi-
variate analyses for each infection-country grouping were in-
cluded into logistic regression models for each infection-burden
group. Within each geographic grouping, we limited the list of
covariates to those that were available for all countries in that
group with the exception of Papua New Guinea, which was
excluded from the multipredictor models because ferritin was not
measured as part of this survey. Each factor was included in the
regression models regardless of the factor’s position in hy-
pothesized causal chains; i.e., even if 2 factors lay on the same
causal chain (e.g., helminth infection and iron deficiency), both
were included in the regression models. Models were constructed
with the use of block stepwise regression whereby variables were
entered into the model in blocks in order of anticipated impor-
tance. The blocks and variables in each block were as follows:
1) main factors (i.e., iron deficiency and inflammation); 2)
nutrition factors (i.e., BMI and vitamin A, folate, and B-12
deficiencies); 3) health factors (ever given birth, currently breast-
feeding, and number of times pregnant); 4) environmental fac-
tors (i.e., household sanitation and water facilities); and 5)
demographic factors (age group, marital status, SES, rural or
urban residence, woman’s educational level, and educational level
of household head).
The anticipated importance of risk factors was determined
according to the BRINDA anemia framework (11) and the
authors’ judgment. Each block of variables was separately
added to its respective infection-group model in the order of
importance, and variables without marginal significance (P. 0.1)
were progressively removed from each block. In addition, a
categorical variable for each survey in the infection group was
included in each model to represent the effects of factors that
were not captured by the other explanatory variables. This sur-
vey variable was retained in each model irrespective of the
significance of the association with anemia. No interaction terms
were investigated during the model-building process, and no
variables were forced into the model. We examined the associa-
tion between anemia and iron deficiency with the use of 3 sep-
arate calculations as follows: 1) the prevalence of iron-deficiency
anemia or the proportion of all women who had concurrent iron
deficiency and anemia; 2) the proportion of iron-deficient and iron-
sufficient women who had anemia; and 3) the proportion of anemic
women who were iron deficient.
RESULTS
Population characteristics
Our study sample was restricted to participants with hemo-
globin values, which excluded 1.9% of WRA (n = 521) from the
analysis. WRA who were excluded because of missing hemoglo-
bin values had a younger mean age (27.2 y) than that of women
who were included in the analysis (29.9 y) but did not have
substantially different SES (data not shown). As shown in Table 1,
27,018 WRA had valid age and hemoglobin measurements. At the
country level, the mean age of the WRA ranged from 27 to 34 y,
and WRA in high-infection and moderate-infection countries were
TABLE 1
Age, hemoglobin concentrations, and anemia prevalence in nonpregnant women of reproductive age by country and category of infection burden: the
BRINDA project1
n Age,2 y Hemoglobin,2 g/L Severe anemia, % Moderate anemia, % Mild anemia, % Any anemia, %
Survey
Cameroon 775 27.2 (26.5, 27.8) 122.6 (120.8, 124.3) 1.3 (0.6, 2.5) 15.7 (12.6, 19.4) 19.3 (16.6, 22.4) 36.3 (31.9, 41.0)
Colombia 9678 29.1 (28.8, 29.3) 141.6 (141.0, 142.1) 0.1 (0.1, 0.3) 4.8 (4.3, 5.3) 3.0 (2.6, 3.6) 8.0 (7.3, 8.7)
Coˆte d’Ivoire 850 27.6 (26.9, 28.3) 118.6 (117.4, 119.9) 2.0 (1.3, 3.1) 23.7 (20.7, 26.9) 24.2 (21.5, 27.1) 49.9 (46.4, 53.3)
Georgia 1711 32.6 (32.0, 33.1) 129.7 (128.0, 131.3) 1.1 (0.6, 1.8) 8.2 (6.7, 10.1) 14.1 (11.9, 16.5) 23.3 (20.4, 26.6)
Laos 823 29.3 (28.6, 30.0) 122.6 (120.3, 124.9) 2.4 (1.5, 3.9) 16.0 (11.8, 21.3) 17.6 (14.5, 21.2) 36.0 (30.6, 41.9)
Liberia 1971 28.6 (28.1, 29.1) 123.7 (122.6, 124.7) 0.2 (0.1, 0.6) 11.3 (9.4, 13.5) 21.7 (19.4, 24.2) 33.2 (29.7, 37.0)
Mexico 2006 3050 31.3 (30.7, 31.9) 136.4 (135.2, 137.5) 0.1 (,0.1, 0.2) 5.2 (4.0, 6.7) 8.6 (6.9, 10.8) 13.9 (11.8, 16.3)
Mexico 2012 4174 32.1 (31.7, 32.5) 135.2 (134.6, 135.9) 0.6 (0.3, 1.1) 4.8 (4.1, 5.7) 7.5 (6.4, 8.7) 12.9 (11.6, 14.3)
Papua New Guinea 760 29.2 (28.5, 29.9) 125.7 (123.1, 128.3) 2.3 (1.5, 3.6) 15.7 (12.0, 20.3) 17.0 (13.6, 21.0) 35.1 (29.0, 41.7)
United States 3226 33.5 (32.9, 34.0) 135.5 (134.5, 136.4) 0.1 (,0.1, 0.2) 2.6 (2.0, 3.4) 4.0 (3.2, 5.0) 6.7 (5.5, 8.0)
Infection burden
Low 4937 33.5 (33.0, 33.9) 135.4 (134.4, 136.3) 0.1 (,0.1, 0.2) 2.7 (2.1, 3.3) 4.1 (3.3, 5.1) 6.9 (5.9, 8.1)
Moderate 16,902 31.2 (31.0, 31.5) 136.8 (136.3, 137.3) 0.3 (0.2, 0.5) 5.0 (4.4, 5.6) 7.1 (6.3, 8.1) 12.4 (11.4, 13.5)
High 5179 27.9 (27.6, 28.2) 121.7 (120.9, 122.5) 1.7 (1.3, 2.2) 18.1 (16.4, 19.9) 20.7 (19.2, 22.2) 40.5 (38.3, 42.6)
1 Severe anemia was defined as a hemoglobin concentration ,80 g/L; moderate anemia was defined as a hemoglobin concentration $80 and ,110 g/L;
mild anemia was defined as a hemoglobin concentration $110 and ,120 g/L; and any anemia was defined as a hemoglobin concentration ,120 g/L.
Hemoglobin concentrations were adjusted for altitude and the intensity of cigarette smoking in the Colombia, Georgia, Papua New Guinea, Mexico 2006, and
Mexico 2012 surveys. In Laos, hemoglobin was only adjusted for altitude, and in the United States, hemoglobin was only adjusted for smoking. No
adjustments to hemoglobin were made in the Coˆte d’Ivoire, Cameroon, and Liberia surveys. Countries were categorized by infection burden as follows—
low: Georgia and the United States; moderate: Colombia and Mexico (2006 and 2012); high: Cameroon, Coˆte d’Ivoire, Liberia, Laos, and Papua New Guinea.
BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia.
2 Values are means (95% CIs).
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slightly younger than were WRA in low-infection countries. The
minimum and maximum ages in all surveys were 15 and 49 y
except for in the Cameroon and Coˆte d’Ivoire surveys in which the
maximum age was 48 y.
Mean hemoglobin concentrations ranged from 119 g/L in Coˆte
d’Ivoire to 142 g/L in Colombia and were noticeably lower in
high-infection countries than in moderate- and low-infection
countries. Severe anemia was relatively rare with a prevalence
of ,2.5% in all countries. The prevalence of moderate anemia
ranged from w3% in the United States to nearly 24% in Cote
d’Ivoire and was .3 times higher in high-infection countries
than in moderate- and low-infection countries. Similarly, the
range in the prevalence of mild anemia was large with a prev-
alence that was 3–5 times higher in high-infection countries than
in moderate- and low-infection countries. Mild anemia accounted
for .50% of all anemia shown in all infection groups. Anemia
was a severe public health problem in Coˆte d’Ivoire, a moderate
public health problem in Cameroon, Georgia, Laos, Liberia,
and Papua New Guinea, and a mild public health problem in
Colombia, Mexico, and the United States. The prevalence of
any anemia in high-infection countries was 28 and 34 percentage
points higher than in moderate- and low-infection countries,
respectively.
The estimated prevalence of iron deficiency on the basis of
inflammation-adjusted ferritin values ranged from 19% to 38% in
all countries except in Georgia where the prevalence was ,2%
(Table 2). The prevalence of iron-deficiency anemia was .10%
in 4 countries (Cameroon, Coˆte d’Ivoire, Laos, and Liberia) in
FIGURE 1 Venn diagrams illustrating the weighted prevalences of iron deficiency, anemia, and iron-deficiency anemia and proportions of anemic women
with iron deficiency in nonpregnant WRA by category of infection burden: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia
(BRINDA) project. Iron deficiency was defined as an inflammation-adjusted ferritin concentration ,15 mg/L. Anemia was defined as a hemoglobin concentration
,120 g/L. Iron-deficiency anemia was defined as a hemoglobin concentration ,120 g/L and inflammation-adjusted ferritin concentration ,15 mg/L. Countries
were categorized by infection burden as follows—low: Georgia and the United States; moderate: Colombia and Mexico (2006 and 2012); and high: Cameroon,
Coˆte d’Ivoire, Liberia, and Laos. WRA, women of reproductive age.
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the high-infection group. The adjustment of ferritin for inflamma-
tion increased the proportion of women with iron deficiency and
iron-deficiency anemia in all countries and infection groups. The
largest change in iron deficiency was observed in the moderate-
infection group where the prevalence increased by 8.4 percentage
points. Despite this large increase in the prevalence of iron de-
ficiency, the largest change in iron-deficiency anemia was
observed in the high-infection group where the prevalence in-
creased by 3.5 percentage points (Figure 1, Supplemental
Figure 2).
In the 5 countries where RBP or retinol was measured inWRA,
the prevalence of vitamin A deficiency was #2% (data not
shown). The prevalence of vitamin A insufficiency ranged from
20% in Liberia to 3% in the United States and was w14% in
high-infection countries with data (Table 2). The prevalence of
any inflammation ranged from 14% in Laos to 34% in Coˆte
d’Ivoire and did not substantially differ in the infection groups.
Cameroon and Liberia had a similar prevalence of malaria, but a
markedly lower prevalence was shown in Coˆte d’Ivoire where
only current malaria was assessed with the use of microscopy.
Serum or plasma folate was only measured in a few countries.
The prevalence of folate deficiency was .80% in both Coˆte
d’Ivoire and Georgia but ,3% in Mexico and the United States.
Similar to folate deficiency, the prevalence of vitamin B-12
deficiency was very low (,3%) in both Mexico and the United
States but was much higher (w15%) in Coˆte d’Ivoire and
Colombia.
Bivariate associations between anemia and iron and
vitamin A deficiencies
Only in the high-infection group was the anemia prevalence
greater than the iron-deficiency prevalence. In the groups with
moderate and low infection burdens, the prevalence of iron de-
ficiency was nearly 3 times greater than the respective group’s
anemia prevalence. Despite the relatively higher prevalence of
iron deficiency in the high-infection group, the contribution
of iron deficiency to anemia, as measured via the proportion of
anemic women with concurrent iron deficiency, increased with a
declining infection burden from 35.1% in the high-infection
group to 65.3% in the moderate-infection group, to 71.0% in the-
low infection group (Figure 1). When calculated with the use of
unadjusted ferritin concentrations, the proportion of anemic
women with iron deficiency was markedly lower as 26.4%,
48.8%, and 46.4% in the groups with low, moderate, and high
infection burdens, respectively (Supplemental Figure 2).
Anemia was most consistently associated with iron deficiency
and vitamin A insufficiency (Table 3). The prevalence of anemia
was higher in iron-deficient women in all countries and all infection
groups. For the high-, moderate-, and low-infection groups, the
anemia prevalence of iron-deficient women was 1.8, 3.7, and 10.7
times higher, respectively, than that of their iron-replete counter-
parts (Supplemental Table 2).
The anemia prevalence in WRAwith vitamin A insufficiency
was higher in Coˆte d’Ivoire, with a greater significance (P, 0.001)
in Cameroon, Liberia, Papua New Guinea, and the United States.
Noteworthy associations (P , 0.05) between anemia and vitamin
A deficiency were shown in 3 of 5 countries (i.e., Liberia, Papua
New Guinea, and the United States) and in the groups with high
and low infection burdens (data not shown).TA
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Bivariate associations between anemia and folate and
vitamin B-12 deficiencies, inflammation, and BMI
The prevalence of anemia did not significantly differ by folate
or vitamin B-12 status. Notably, small sample sizes for folate
status in Georgia (n = 401) and for vitamin B-12 in Coˆte d’Ivoire
(n = 398) and Colombia (n = 637) may have affected the sen-
sitivity of the analyses in those countries. Mixed results were
observed for any inflammation; the prevalence of anemia in
WRAwith inflammation was significantly higher in all countries
except Colombia, Laos, and Mexico. Significant differences in
anemia prevalence by inflammation status were shown in the
groups with high and low infection burdens but not in the groups
with a moderate infection burden.
Mixed associations between anemia and BMI were also ob-
served with significant differences in high– and low–infection-
burden groups but not in the moderate–infection-burden group
(Table 3). Notably, high- and low-infection groups had opposite
trends in the prevalence of anemia and BMI whereby, in high–
infection-burden group, anemia prevalence decreased with in-
creasing BMI, whereas anemia prevalence and BMI increased in
tandem in the low-infection group. Although the prevalence of
anemia was consistently higher in WRA with malaria, these dif-
ferences were NS in 2 of 3 countries or in the pooled analyses.
Bivariate associations between anemia and
demographic factors
The demographic factors that were explored varied by survey,
but SES showed a consistent and mostly significant association
with anemia prevalence (Table 4). For all countries except
Cameroon, Liberia, and Papua New Guinea, SES was signifi-
cantly inversely associated with anemia, and significant differ-
ences were observed in all pooled infection groups. Moreover, a
clear trend in anemia was observed with prevalence consistently
decreasing from the low- to high-socioeconomic groups. WRA
in different age groups showed significant differences in the
prevalence of anemia in some countries and infection groups;
however, there was only a clear trend in the Colombia, Liberia,
and Mexico (2012) surveys and moderate–infection-burden group.
In the Colombia and Mexico 2012 surveys and the moderate–
infection-burden group, the prevalence of anemia increased with
age, whereas in Liberia, the prevalence of anemia decreased
with age.
In Cote d’Ivoire, Laos, and Papua New Guinea, rural residents
had a higher prevalence of anemia than did urban residents.
Significant associations between household sanitation and ane-
mia were observed in Laos only with the anemia prevalence in
WRA residing in households practicing open defection being
notably higher than in households with the use of improved or
unimproved latrines. This strong country-level association was
likely responsible for the significant difference that was observed
in the high-infection group. Significant associations between the
quality of the household water source and the prevalence of ane-
mia were observed in Liberia only where the prevalence of anemia
was lower in WRA who were residing in households that con-
sumed water from unimproved sources. The water source was not
significantly associated with anemia in the pooled analyses. Only
in Laos was there a significant association and a clear trend between
education status and the prevalence of anemia. Education status and
anemia were associated with significance in the high-infectionTA
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group, and the anemia prevalence in WRA with no formal edu-
cation was w10 percentage points higher than in WRA in other
education subgroups.
Multivariable models of associations with anemia
Results from the pooled multivariable analyses for each in-
fection group are presented in Table 5. In the high-infection
group, independent predictors of anemia included iron defi-
ciency, inflammation, and vitamin A insufficiency. All other
potential predictors were removed from the model because they
were NS. The odds of anemia in iron-deficient women was 3.7
times higher than that of iron-replete women. In addition,
women with inflammation (elevated CRP or AGP) had 1.9 times
the odds of being anemic than that of women with no inflammation.
Similarly, the odds of anemia in vitamin A–insufficient women was
1.7 times higher than in vitamin A–replete women. These results
were all highly significant (P , 0.001).
In moderate-infection countries, iron deficiency, age, and SES
were significant predictors of anemia. Other predictors that were
NS were removed from the model. Iron-deficient women had 4.3
times the odds of being anemic than that of iron-replete women
(P , 0.001). Compared with the reference group (i.e., high
SES), the odds of anemia were significantly higher in the low-
socioeconomic group (OR 1.8; 95% CI: 1.4, 2.4) and moderate-
socioeconomic group (OR 1.6; 95% CI: 1.2, 2.2) (P , 0.001).
Regarding age, the odds of being anemic were 50% higher in
women aged 40–49 y than in women aged 15–19 y.
In the low–infection-burden model, iron deficiency, inflam-
mation, and age were significant predictors of anemia status.
Other factors were removed from the model because they were
NS. Iron-deficient women had nearly 17 times the odds (95% CI:
11.5, 24.6) of being anemic than did their iron-replete coun-
terparts (P , 0.001). The odds of anemia in women with in-
flammation were 50% greater (OR 1.5, 95% CI: 1.006. 2.1) than
in women without inflammation (P , 0.05). As regards age, the
odds of anemia in women aged 20–29 and 30–39 y were similar to
those of the reference population (i.e., women aged 15–19 y).
Only women aged 40–49 y had significantly higher odds of
anemia than those in the reference group.
DISCUSSION
Our results on factors associated with anemia were based on
the analysis of individual-level biomarker data and, as such, differ
from other recently-published multicountry analyses by Kasse-
baum et al. (13) and Petry et al. (25). Kassebaum et al. (13)
estimated the contribution of numerous risk factors to anemia by
estimating the “hemoglobin shift” or impact of a risk factor on
hemoglobin concentrations; systematic reviews and meta-analyses
were used to estimate the hemoglobin shift for each risk factor.
The authors showed that iron deficiency was the single greatest
contributor to anemia globally but that other factors (e.g., malaria
and helminths) also contributed substantially to the anemia burden
in some regions. Although the authors used a rigorous approach,
their model could not take into account the severity of iron de-
ficiency in each country. Contrarily, the analysis by Petry et al.
(25) focused solely on the contribution of iron deficiency to anemia.
By conducting a meta-analyses of 23 national-level data sets
containing results of anemia and iron deficiency, they showed that,
TABLE 5
Logistic regression models of factors associated with anemia in nonpregnant women of reproductive age by category of
infection burden: the BRINDA project1
Variable
Low infection burden Moderate infection burden High infection burden
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Iron deficiency 16.8 (11.5, 24.6) ,0.001 4.3 (3.4, 5.4) ,0.001 3.7 (2.9, 4.8) ,0.001
Inflammation 1.5 (1.01, 2.1) 0.046 — 1.9 (1.5, 2.4) ,0.001
Vitamin A insufficiency — — 1.7 (1.2, 2.3) ,0.001
Age group, y
15–19 Reference ,0.01 Reference 0.015 —
20–29 0.78 (0.45, 1.3) 0.97 (0.6, 1.6) —
30–39 1.1 (0.68, 1.8) 1.3 (0.89, 1.8) —
40–49 1.7 (1.05, 2.6) 1.5 (1.1, 2.2) —
Socioeconomic status
Low — 1.8 (1.4, 2.4) ,0.001 —
Moderate — 1.6 (1.2, 2.2) —
High — Reference —
1Anemia status (yes or no) was used as the outcome variable in all models. Countries were categorized by infection
burden as follows—low: Georgia and the United States; moderate: Colombia and Mexico (2006 and 2012); high: Came-
roon, Coˆte d’Ivoire, Liberia, and Laos. As the Papua New Guinea survey did not measure ferritin, it was not included in the
high infection burden model. Iron deficiency was defined as an inflammation-adjusted ferritin concentration ,15 mg/L.
Inflammation was defined as a C-reactive protein concentration .5 mg/L or a-1-acid glycoprotein concentration .1 g/L.
Vitamin A insufficiency was defined as an unadjusted retinol-binding protein or retinol concentration ,1.05 mmol/L. CIs
were adjusted for survey weights that were proportional to the size of the target population in each country. Em dashes
denote variables that were not included in the final regression models because of a lack of significance. Other variables (i.e.,
BMI, folate and vitamin B-12 deficiencies, ever given birth, currently breastfeeding, number of times pregnant, household
sanitation, household water facilities, marital status, rural or urban residence, woman’s education level, and education level
of the household head) were removed from the various models because of a lack of significance. BRINDA, Biomarkers
Reflecting Inflammation and Nutritional Determinants of Anemia.
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in nonpregnant WRA, 37% of anemia was attributable to iron
deficiency, and the proportion of anemia that was attributable to
iron deficiency was lowest (w18%) in women in countries where
anemia was a severe public health problem. Similar to the findings
by Kassebaum et al. (13), there was considerable variability in the
proportion of anemia that was attributable to iron deficiency by
region.
Our findings support those of Kassebaum et al. (13) and Petry
et al. (25) and confirm that the assumption that 50% of anemia is
attributable to iron deficiency cannot be consistently applied to
WRA. Furthermore, our analysis suggests that this approximation
may overestimate the proportion of anemia that is attributable to
iron deficiency in countries with a high infection burden and un-
derestimate the same in countries with a lower infection burden. In
addition, the overall prevalence of anemia and iron deficiency and
their ratio to each other varied dramatically by infection group,
thereby strongly suggesting that the anemia and iron-deficiency
burden is not uniform and varies by setting.
Individual studies in other countries with high infection
burdens have shown similar findings. In Sierra Leone (38), 45%
of nonpregnant WRAwere anemic, but only 8% and 6% of them
had iron deficiency and iron-deficiency anemia, respectively.
Despite the small prevalence of iron deficiency in Sierra Leonean
women, iron deficiency was significantly associated with anemia
in multivariate models but only contributed to 11% of anemia. In
the Democratic Republic of the Congo, Harvey-Leeson et al. (19)
showed a moderate prevalence of anemia in the South Kivu
(17%) and Kongo Central (32%) provinces but only 5% of iron
deficiency and ,1% of iron-deficiency anemia in both provinces.
In rural Bangladesh, Merrill et al. (39) observed a high prevalence
of anemia (57%) and complete absence (0%) of iron deficiency
and speculated that anemia was most attributable to increased
parity, and high body iron stores were due to high levels of iron in
the groundwater.
An understanding of the proportion of anemia that is attrib-
utable to iron deficiency is particularly relevant to the design and
implementation of public health programs such as the fortifi-
cation of staple foods with iron and the promotion and distri-
bution of iron supplements. The fortification of cereal grains with
iron is currently mandatory in 85 countries (40) with wheat,
maize, and rice being the most widely fortified food grains. Staple
condiments, such as soy sauce and bouillon cubes (41), are also
increasingly fortified with iron, and home-fortification products
that contain iron are also designed specifically for pregnant
women (42). Accompanying this suite of fortified foods are pro-
phylactic iron supplements, which theWHO recently recommended
for “menstruating adult women and adolescent girls” in settings
where anemia is .40% (43).
Fortification and supplementation interventions often have the
explicit aim to reduce anemia, but data on the etiology of anemia
are lacking for many countries. Moreover, the use of anemia
prevalence as a criterion for implementing iron interventions may
not be the most effective approach particularly where the infection
burden is high. To illustrate, a recent systematic review of flour-
fortification–effectiveness studies showed that flour-fortification
programs (all containing iron fortificants) more consistently re-
duced iron deficiency than anemia (44). In contrast, a systematic
review of daily iron supplementation showed consistent associa-
tions with improved hemoglobin concentrations and reductions in
anemia (45). Both reviews noted that there are only limited data
available on the effectiveness of iron interventions and suggested
that, particularly for fortification programs, programs may be more
effective at reducing iron deficiency than anemia.
In our analysis, vitaminA statuswas only available for 5 countries,
4 of which (Cameroon, Coˆte d’Ivoire, Liberia, and Papua New
Guinea) were included in the high-infection group. Thus, there were
insufficient data to measure this association in the moderate- and
low-infection groups. Nonetheless, for the high-infection group, our
findings suggest that vitamin A insufficiency independently con-
tributes to anemia in women. Radhika et al. (46) showed similar
results in pregnant women from India with a significant associa-
tion between vitamin A deficiency (serum retinol concentration
,1.05 mmol/L) and anemia.
Inflammation, as defined by elevated CRP or AGP, was repeatedly
associated with anemia in our analysis. The inflammatory response
can induce anemia via the downregulation of iron absorption and
erythropoiesis (47); independent associations between inflammation
and low hemoglobin concentrations have been reported in Denmark
(48), Sierra Leone (38), and the United States (49). Despite our
separation of countries into groups on the basis of infection burden,
we showed a similar inflammation prevalence (22–26%) in the in-
fection groups. Inflammation has multiple causes, and significant
associations between inflammation and anemia in both the high-
and low-infection groups may have reflected inflammation stem-
ming from different causes. As part of this supplement, Merrill
et al. (50) showed that a positive malaria status was significantly
associated with both acute inflammation (i.e., elevated CRP) and
chronic inflammation (i.e., elevated AGP) in WRA in Cameroon,
Coˆte d’Ivoire, and Liberia. They also showed that the associations
between acute inflammation and obesity were largely consistent;
the odds of elevated CRP were 3–8 times higher in obese women
than in normal-weight women in 7 of 9 countries.
Although we did not find an association between inflammation
and anemia in the moderate-infection group, note that this group
was comprised of only the Colombia, Mexico 2006, and Mexico
2012 surveys, which did not include AGP as a measure of chronic
inflammation. The absence of AGP as an indicator could have
resulted in a weaker relation between inflammation and anemia in
this group.
A similar pattern of associations was shown between age and
anemia in the moderate- and low-infection groups with the
prevalence of anemia being highest in women aged 40–49 y.
These finding are somewhat different to anemia-age trends that
were calculated by Kassebaum et al. (13) who observed a steady
decline in anemia prevalence in women after w20 y of age.
Sekhar et al. (51) showed that the risk factors for iron-deficiency
anemia differed in adolescent girls (aged 12–19 y) and adult
women (aged 21–49 y) with the use of contraception reducing
risk in adolescent girls and the number of live births being as-
sociated with increasing risk in older women.
The lack of an association between malaria and anemia in the
multivariate model may have been due to the fact that malaria was
not assessed in a standardized manner in the 3 West African
surveys. In addition, because of the significant association be-
tween malaria and inflammation (50), inflammation may have
served as a proxy measure of malaria in the 3 surveys from West
Africa.We also showed no association between anemia and folate
and vitamin B-12 deficiencies, which is a finding that is supported
by Metz (52), who conducted a review of studies that examined
the hematologic effects of folate and vitamin B-12 deficiencies.
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Folate and vitamin B-12 were measured in 50% of the surveys,
and small sample sizes in a few surveys may have affected the
sensitivity of the analysis.
Although the interpretation of ferritin concentrations is
complicated by the presence of inflammation, our analysis took
advantage of newer methods for mathematically adjusting these
indicators for inflammation, namely, the use of a regression
approach rather than the application of correction factors on the
basis of infection categories as proposed previously by Thurnham
et al. (29, 30). The regression approach resulted in a greater
reduction in the prevalence of iron deficiency than shown with
correction-factor approaches; this difference in iron assessment
may explain some inconsistencies with the results of other studies.
Note that the regression approach was not used to adjust RBP and
retinol because the BRINDA project showed inconsistent asso-
ciations between inflammation and vitamin A–status markers in
women (31). Although the unadjusted RBP and retinol values
appeared to not have been affected by inflammation, even a
weak or nonlinear association between inflammation and vitamin
A status could have affected the associations shown between
vitamin A insufficiency and anemia.
Our analysis has some notable limitations. First, data were
cross-sectional, which prevented any temporal analysis of cau-
sation. Second, the multivariate approach that we used did not
take into account the relations between the predictor variables; as
such, future analyses should explore statistical methods (e.g., a
path analysis) that permit the estimation of the direct and indirect
influences of predictors on anemia status. Third, the BRINDA
data set used only hemoglobin to measure anemia and did not
contain other hematologic measures (e.g., mean corpuscular
volume) that can be used to determine microcytic or macrocytic
anemia and could have better elucidated the interrelation between
the risk factors for anemia (53). Fourth, not all data sets contained
measures of AGP, which compromised the measurement of in-
flammation. Fifth, the BRINDA data set did not include other
potential determinants of anemia such as hemoglobinopathies,
helminth burden, and HIV status, which may have a role in
certain settings (12), and not all data sets contained data on folate
and vitamin B-12 deficiencies. Sixth, the BRINDA project
only contained a small number of data sets that were subsequently
classified into the high-, moderate-, and low-infection groups.
The small number of studies in these groups limits the gener-
alizability of our findings, particularly for the pooled analyses of
the low-infection group, because the weights that were based on
the proportional population size of each country limited the
contribution of Georgia because of its relatively small population
size. Last, the grouping of countries by infection group may
represent other factor differences besides infection, including the
SES of the country, dietary patterns, and access to health care.
In conclusion, particularly in countries where the prevalence of
anemia is a moderate or severe public health problem, more data
elucidating the etiology of anemia are needed. The data that were
used in our analysis are relatively rare and greater efforts are
needed to collect and compile similar data in other countries that
experience high anemia prevalence. A context-specific under-
standing of the determinants of anemia is needed to design and
evaluate national health programs that aim to reduce anemia.
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